- Institution: Stanford Univ Med Ctr Lane Med Lib/Periodical Dept/Rm L109
- Sign In as Member / Individual
Neuronal Nicotinic Receptor Subtypes: DEFINING THERAPEUTIC TARGETS
Figure 2.
Cytoprotection afforded by choline analogs. Data represent the ability of nicotine and 7 tertiary amine analogs of choline to protect differentiated PC-12 cells from the cytotoxicity associated with growth factor withdrawal. Horizontal and vertical lines within each graph show concentrations that afford 50% cytoprotection.
